Inovio Pharmaceuticals, Inc. INO

1.18 (0.03) (2.48%) as of 25 Sep
Market cap
$126.9M
P/E
0.0×
Growth Flags show if company had growth for consecutive years

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
104.77 127.43 81.23 89.53 411.64 401.31 253.00 145.29 94.11 58.51
Receivables
16.57 6.49 4.05 2.03 19.06 8.03 11.74 2.41 1.20 —
Total current assets
124.60 138.36 87.81 94.20 471.17 448.44 315.24 153.11 97.83 61.12
Property, Plant, Equpment (Net)
9.03 18.32 15.95 12.77 11.35 17.45 7.73 4.96 3.66 2.53
Long-Term Investments
19.83 11.39 9.41 6.32 4.89 3.91 2.01 2.78 1.61 2.10
Goodwill and Intangible Assets (Total)
18.14 16.52 15.27 14.21 13.66 13.14 12.64 — — —
Long-term assets (Other)
2.11 2.64 2.67 2.67 25.96 1.43 0.68 0.61 1.98 2.01
Total non-current assets
49.11 48.88 43.30 49.75 68.60 47.50 33.29 17.84 15.37 13.19
Total Assets
173.71 187.24 131.11 143.95 539.77 495.94 348.53 170.95 113.20 74.31
Notes Payable
— — — — — — — 16.77 — —
Accounts Payable
20.67 24.21 24.11 18.97 21.85 48.19 80.91 20.92 17.55 11.13
Accrued Expenses
6.37 8.61 5.67 4.05 9.95 10.33 10.59 2.37 2.02 0.65
Current Revenue (Deferred)
15.62 2.23 5.52 6.90 7.58 4.62 2.56 0.11 — —
Other current liabilities
1.17 0.36 24.28 22.27 37.91 38.38 72.98 — 13.26 29.07
Total current liabilities
43.82 35.41 35.30 31.99 41.71 65.74 96.87 42.57 35.33 43.67
Long Term Debt (Total)
— — — 77.02 18.66 14.96 16.61 — — —
Non-current Revenue (Deferred)
0.40 0.22 0.15 0.24 0.12 0.06 — — — —
Long Term Tax Liability (Deferred)
6.10 9.13 8.54 0.03 0.03 0.03 0.03 — — —
Non-current Liabilities (Other)
5.93 9.10 0.09 8.86 0.06 0.01 — — — —
Total non-current liabilities
6.51 9.35 8.78 106.56 36.93 30.53 29.30 11.03 9.37 6.55
Total liabilities
50.33 44.75 44.08 138.55 78.63 96.27 126.17 53.60 44.69 50.21
Additional Paid In Capital
556.72 665.78 707.79 742.65 1,367.41 1,609.59 1,710.89 1,740.95 1,799.36 1,839.83
Common Stock (Net)
0.07 0.09 0.10 0.10 0.19 0.22 0.02 0.02 0.04 0.07
Retained Earnings
(434.84) (523.36) (620.43) (739.79) (906.20) (1,209.85) (1,487.85) (1,622.96) (1,730.22) (1,815.16)
Common Equity (Total)
123.38 142.49 87.03 5.40 461.14 399.67 222.36 117.35 68.50 24.10
Shareholders Equity (Total)
123.38 142.49 87.03 5.40 461.14 399.67 222.36 117.35 68.50 24.10
Shareholders Equity and Liabilities (Total)
173.71 187.24 131.11 143.95 539.77 495.94 348.53 170.95 113.20 74.31
Shares (Common)
6.17 7.53 8.10 8.44 15.56 18.11 21.09 22.79 37.00 69.00
Shares (Preferred)
— — — — — — — — 0.00 0.00
Shareholders Equity (Tangible)
105.24 125.97 71.76 (8.80) 447.48 386.53 209.72 117.35 68.50 24.10
Net Debt
(104.77) (127.43) (81.23) (12.51) (392.99) (386.35) (236.38) (145.29) (94.11) (58.51)
Total Debt
— — — 77.02 18.66 14.96 16.61 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates